课题基金 / 基金详情

Exploring Novel Targeting Strategies for AIDS Protozoal Pathogens

Exploring Novel Targeting Strategies for AIDS Protozoal Pathogens
探索艾滋病原虫病原体的新靶向策略
批准号:
7994166
负责人:
Karen S. Anderson
金额:
$40.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2013-11-30

项目摘要

项目成果

Karen S. Anderson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In the last decade, major strides have been made in antiviral therapies for treatment of AIDS due to HIV infection. Currently, opportunistic infections are the primary cause of suffering and death in individuals with AIDS. Many of these infections are produced by parasites that rarely affect individuals who are not immunocompromised. Unfortunately, successful combination therapies against the HIV-1 virus still leave most patients susceptible to opportunistic parasitic infections. There are few drugs available to treat these parasitic infections. The drugs that are available suffer from a lack of selectivity, resulting in host toxicity, untoward side effects, and ineffectiveness due to development of resistance. Thus there is a need to identify novel targeting strategies that may ultimately lead to therapeutics that are more selective and less toxic. This proposal outlines mechanistic and structural studies that focus on unique bifunctional enzymes present only in parasites that may serve as a potential target for the discovery of novel anti-parasitic drugs for treatment of opportunistic infections in AIDS patients. The central theme of this proposal is that an integrated mechanistic, structural and computational evaluation of the parasitic bifunctional TS-DHFR enzyme at a molecular level will help to identify novel targeting strategies for these unique bifunctional enzymes and provide the necessary proof-of-concept to establish non-active site inhibitors as an effective and novel therapeutic approach. A long-term goal of the proposed research is to take advantage of the unique differences between parasitic and human enzymes and develop novel antiparasitic drugs for the treatment of opportunistic parasitic infections. To accomplish this goal requires a multi-disciplinary approach. We have assembled a strong collaborative team with a proven track record that will have the necessary mechanistic, structural, synthetic, computational and cell biology experience to attack this problem. There are two specific aims in this proposal both focused on comprehensive studies of protozoal bifunctional TS-DHFR enzymes. PUBLIC HEALTH RELEVANCE: Opportunistic infections are the primary cause of suffering and death in individuals with AIDS. Many of these infections are produced by parasites that rarely affect individuals who are not immunocompromised. Unfortunately, successful combination therapies against the HIV-1 virus still leave most patients susceptible to opportunistic parasitic infections and new therapies are desperately needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism and Inhibition of HIV Reverse Transcriptase
  • 批准号:
    10407019
  • 项目类别:
  • 资助金额:
    $74.27万
  • 财政年份:
    2020
  • 负责人:
    Karen S. Anderson
  • 依托单位:
Mechanism and Inhibition of HIV Reverse Transcriptase
  • 批准号:
    10203819
  • 项目类别:
  • 资助金额:
    $74.27万
  • 财政年份:
    2020
  • 负责人:
    Karen S. Anderson
  • 依托单位:
Mechanism and Inhibition of HIV Reverse Transcriptase
  • 批准号:
    10082250
  • 项目类别:
  • 资助金额:
    $74.27万
  • 财政年份:
    2020
  • 负责人:
    Karen S. Anderson
  • 依托单位:
Mechanism and Inhibition of HIV Reverse Transcriptase
  • 批准号:
    10620697
  • 项目类别:
  • 资助金额:
    $74.27万
  • 财政年份:
    2020
  • 负责人:
    Karen S. Anderson
  • 依托单位:
海外基金